Sponsor Trends Dashboard
In the last post here, we gained some insights into top performing sponsors and overall trend. In this post, we will look further deep into how the sponsor participation has changed in last few years. The Sponsor Trends Dashboard (figure 6.1) can answer some interesting questions and see what's going on in the clinical trials industry.
 |
| Figure 6.1 |
Here, we will try to analyze the insights gained from Sponsor Trends Dashboard in Figure 6.1 above.
1. What type of study Sponsors have the highest or lowest share in study registration, and how has that changed over the last few years?
The chart in Quadrant 2 tells us about the share of studies by different types of sponsors. Clearly, Universities have the highest share and has maintained a steep rise in the last few years. The share has increased from 40% in 2005 to 50% in last 2 years. These Universities could be public or private, funded or not-funded but we do not have that information available as of now.
Hospitals have also performed well in registering the studies. The share of studies registered by Hospitals have almost doubled since 2005. On the other hand, the share of Industry sponsored studies has declined consistently and it has reduced to just 17% now which was 37% in 2008. The share does not indicate if the segment has really grown or declined. The share of one segment, Universities for example, could rise because other segments have declined. To see the trend, read the next question below.
2. Which type of sponsors have shown growth in study activity?
The chart in Quadrant 1 shows how the registered studies by different categories or types of sponsors have grown over the period.
The studies registered by Universities have grown at a continuous and rapid pace. Until 2008, the Industry segment and Universities were overlapping but after that the Universities completely outpaced the Industry Sponsors. The growth in studies registered by Industry sponsors has remained almost flat but Hospitals maintained a steady growth until 2016 after which the growth is negligible.
3. How has the total numbers of sponsors changed over the past few years?
In the above 2 charts in Quadrants 1 and 2, we looked at the trend of the studies registered by sponsors but now in this chart on quadrant 3, we will look at the trend of actual number of sponsors.
The overall trend shows that the total number of primary sponsors who registered their studies has grown consistently. All 3 important categories, Universities, Industry Sponsors and Hospitals have grown consistently. All 3 types of sponsors have increased almost 2 times of 2008 levels.
4. Has the participation of sponsors from industry has increased?
The chart in quadrant 4 shows the participation trend over the period. Industry participation means that either the study is sponsored by a sponsor from industry or at least one of the collaborators is an industry sponsor.
The chart shows that the industry participation has declined and reduced to just 22% from upper 40s in 2008. Between 2005 and 2008, the share of studies having industry participation remained in upper 40s but started declining consistently after 2008. However, it is not clear from this chart if the studies with industry participation has decreased or the studies without industry participation has increased. To figure that out, let's take a look at the trend chart that shows the number of studies with or without industry participation over the period of time.
 |
| Figure 6.2 |
The trend in chart (figure 6.2) shows that the number of studies where there is industry participation has remained nearly constant but the studies without any industry participation has increased from 6K levels in 2005 to 24K in 2018, which is four times growth.
As a food for thought, how do you think clinical research industry can increase the collaboration for the larger benefit to the whole community?
Do post your questions and comments.
Keep thinking!
Source data extracted from: https://aact.ctti-clinicaltrials.org
Primary Sponsor Dashboard
Primary Sponsor dashboard (Figure 5.1) provides us insights into the study activities by primary or lead study sponsors. Primary sponsor is an important stakeholder in the clinical trials that has the primary responsibility of initiating, study design and study conduct. In simple terms, we can say that the primary sponsor is the owner of the clinical study. The sponsor can be an individual, a company or an institution, and they can be from industry (commercial) like pharmaceutical or Biotech companies or public non-industry (non-commercial) institutions like government or research institutions.
In this dashboard we will look at various aspects of study activities of sponsors.
 |
| Figure 5.1 |
1. How many sponsors have registered clinical trials in the US? How many of them are from the Industry (Commercial)? How many studies have they registered? For how many studies did the sponsors from commercial sector have posted the results for the studies?
The tiles on the top provides few sponsors related summary metrics to answer some of the questions mentioned above.
There are a total of 313,345 studies registered by 28,068 lead or primary sponsors in the US till date. Out of 28,068 sponsors, 8,717 sponsors are from commercial sector with 81,169 studies registered and the remaining 19,351 sponsors are from non-commercial sector with 232,176 studies registered.
There are 4,545 sponsors with at least one study result posted and 1,680 of them are from Industry.
2. What percentage of studies were registered by sponsors from industry as compared to the non-industry?
About 26% of studies were sponsored from the industry or commercial sector. A small percentage 3.31% and 1.16% are contributed by NIH (National Institute of Health) and US government respectively. The raw data did not provide further classification into the non-industry sector. The data is transformed to figure out if the non-industry sponsor is a Hospital or University/Institute/School. The shows that Universities have been a major source of sponsored studies with almost 45% share and Hospitals having 9% share.
3. What's the growth in number of studies sponsored by study as compared to the non-industry sector over the last few years?
Except 2008 and 2014, the number of studies registered by Industry sponsors have largely remained stable around 5,500 mark. In contrast, the studies registered by non-industry sponsors have grown rapidly. Notice the size of the steps in the chart. Also notice the increasing gap between the two lines.
4. What percentage of registered studies have some participation from industry?
The pie chart named Industry Participation shows the share of studies where either the primary sponsor is from industry or at least one of of the collaborators is from industry. About 33% of the studies has some participation from industry.
5. Who are the top performing industry sponsors?
The tabular chart shows the primary sponsors from industry sector ranked based on the number of studies registered. The chart also display metrics like number of countries they have recruited patients, number of recruiting facilities, studies in completed state, studies where the recruitment has not yet started, studies that are currently recruiting and studies where results are posted. The success ratio compares the studies that were registered minus the studies that have not yet started or are in progress with the completed studies.
GlaxoSmithKline(GSK) is the top performer with 3351 studies and 91% success ratio followed by Pfizer and Novartis. Pfizer has recruited patients in 105 countries. Sanofi is another sponsor that recruited patients in 107 countries.
6. Who are the top performing sponsors from non-commercial sector?
National Institute of Health Clinical Center, National Cancer Institute and M.D Anderson Cancer Institute are top 3 performers. The non-industry sponsors have recruited patients in fewer countries as compared to the top sponsors from commercial sectors.
The dashboards can answer many other questions by simply slicing and dicing the data by different dimensions.
If you get any questions in your mind that you want to share, please post them in comments and I will try to address them.
Till next time.
